Results 71 to 75 of about 3,853 (75)

Oral Pharmacological Activation of Hypothalamic Guanylate Cyclase 2C Receptor Stimulates Brown Fat Thermogenesis to Reduce Body Weight

open access: closedNeuroendocrinology, 2020
Linaclotide is a synthetic peptide approved by the FDA for the treatment of constipation-predominant irritable bowel syndrome and chronic constipation. Linaclotide binds and activates the transmembrane receptor guanylate cyclase 2C (<i>Gucy2c</i>).
Cintia, Folgueira   +11 more
openaire   +3 more sources

Guanylate cyclase 2C ( GUCY2C ; GUC )expression and the tumor immune microenvironment (TIME) in gastrointestinal (GI) cancers.

open access: closedJournal of Clinical Oncology
3538 Background: An immunosuppressive TIME can result in reduced efficacy of immune checkpoint inhibitors (ICIs) in GI tumors. GUC is preferentially expressed in colorectal (CRC), gastroesophageal junction (GEJ) and gastric adenocarcinoma (GA).
Paul Sackstein   +14 more
openaire   +2 more sources

1017 - Guanylate Cyclase 2C Activation Rescues the Folding Defect in F508Del CFTR

open access: closedGastroenterology, 2018
Kavisha Arora   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy